MMP14 Regulates VEGFR3 Expression on Corneal Epithelial Cells

Area of Science:

• Ophthalmology
• Molecular Biology
• Cell Biology

Background:

• Vascular endothelial growth factor receptor 3 (VEGFR3) is crucial for blood and lymphatic vessel development.
• Corneal avascularity is essential for maintaining vision clarity.
• Matrix metalloproteinase 14 (MMP14) is a protease implicated in tissue remodeling.

Purpose of the Study:

• To investigate if matrix metalloproteinase 14 (MMP14) influences vascular endothelial growth factor receptor 3 (VEGFR3) expression in corneal epithelial cells.
• To determine the role of MMP14 in regulating corneal avascularity through VEGFR3 modulation.

Main Methods:

• Western blot analysis to compare VEGFR3 protein levels in wild-type and MMP14-deficient corneal epithelial cells.
• Quantitative RT-PCR to assess VEGFR3 gene expression.
• In vitro proteolysis assays to test direct cleavage of VEGFR3 by MMP14.
• Proteomic analysis to identify differentially expressed nuclear proteins.

Main Results:

• VEGFR3 protein and gene expression were significantly higher in MMP14-deficient corneal epithelial cells compared to wild-type.
• MMP14 deficiency did not affect VEGFR3 expression in corneal keratocytes.
• MMP14 did not directly cleave VEGFR3 in vitro.
• Proteomic analysis revealed differential expression of 39 nuclear proteins between wild-type and MMP14-deficient corneal epithelial cells.

Conclusions:

• MMP14 appears to regulate VEGFR3 expression at the transcriptional level in corneal epithelial cells.
• The mechanism of MMP14's regulation of VEGFR3 in epithelial cells may involve nuclear protein modulation, not direct cleavage.
• These findings suggest a novel pathway influencing corneal avascularity.